athenahealth, Inc. (NASDAQ:ATHN)‘s stock had its “hold” rating reissued by equities researchers at Canaccord Genuity in a research note issued to investors on Monday, The Fly reports. They currently have a $123.00 price objective on the health services provider’s stock, down from their previous price objective of $144.00. Canaccord Genuity’s price target would indicate a potential downside of 2.41% from the stock’s previous close.

Several other analysts have also commented on the stock. First Analysis upgraded shares of athenahealth from an “underweight” rating to an “equal weight” rating and raised their price target for the company from $125.00 to $127.00 in a research report on Monday. Robert W. Baird restated a “buy” rating and set a $155.00 price target on shares of athenahealth in a research report on Sunday. Royal Bank Of Canada set a $144.00 price objective on shares of athenahealth and gave the company a “hold” rating in a report on Friday. Oppenheimer Holdings, Inc. reaffirmed a “buy” rating and set a $184.00 price objective on shares of athenahealth in a report on Friday. Finally, KeyCorp decreased their price objective on shares of athenahealth from $170.00 to $140.00 and set an “overweight” rating on the stock in a report on Friday. Two equities research analysts have rated the stock with a sell rating, fourteen have assigned a hold rating and eleven have assigned a buy rating to the stock. athenahealth currently has an average rating of “Hold” and an average target price of $147.74.

athenahealth (NASDAQ ATHN) opened at 126.04 on Monday. The stock has a market cap of $5.03 billion, a PE ratio of 159.95 and a beta of 1.76. The company’s 50 day moving average is $125.37 and its 200-day moving average is $130.33. athenahealth has a 1-year low of $90.11 and a 1-year high of $158.66.

athenahealth (NASDAQ:ATHN) last released its quarterly earnings results on Thursday, October 19th. The health services provider reported $0.56 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.50 by $0.06. The company had revenue of $304.60 million for the quarter, compared to analyst estimates of $310.52 million. athenahealth had a net margin of 2.65% and a return on equity of 6.94%. The firm’s revenue was up 10.1% on a year-over-year basis. During the same quarter last year, the business earned $0.60 earnings per share. Equities research analysts forecast that athenahealth will post $1.91 earnings per share for the current fiscal year.

TRADEMARK VIOLATION NOTICE: This news story was first reported by American Banking News and is the property of of American Banking News. If you are accessing this news story on another publication, it was copied illegally and reposted in violation of U.S. and international trademark and copyright laws. The legal version of this news story can be read at https://www.americanbankingnews.com/2017/10/23/athenahealth-inc-athn-stock-rating-reaffirmed-by-canaccord-genuity.html.

In related news, Director Brandon H. Hull sold 800 shares of the company’s stock in a transaction on Tuesday, August 1st. The shares were sold at an average price of $140.01, for a total value of $112,008.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, SVP Jonathan D. Porter sold 300 shares of the company’s stock in a transaction on Tuesday, August 15th. The shares were sold at an average price of $142.88, for a total transaction of $42,864.00. The disclosure for this sale can be found here. Insiders have sold a total of 15,783 shares of company stock valued at $2,132,924 in the last 90 days. Insiders own 3.20% of the company’s stock.

A number of institutional investors and hedge funds have recently made changes to their positions in the business. FMR LLC increased its stake in athenahealth by 0.8% in the 2nd quarter. FMR LLC now owns 5,975,119 shares of the health services provider’s stock valued at $839,803,000 after buying an additional 47,341 shares during the period. Janus Henderson Group PLC acquired a new stake in athenahealth in the 2nd quarter valued at about $713,856,000. Vanguard Group Inc. grew its stake in athenahealth by 1.8% in the 2nd quarter. Vanguard Group Inc. now owns 3,100,643 shares of the health services provider’s stock valued at $435,795,000 after acquiring an additional 53,361 shares during the last quarter. Capital Research Global Investors grew its stake in athenahealth by 15.5% in the 2nd quarter. Capital Research Global Investors now owns 2,041,714 shares of the health services provider’s stock valued at $286,963,000 after acquiring an additional 273,660 shares during the last quarter. Finally, BlackRock Inc. grew its stake in athenahealth by 2.0% in the 2nd quarter. BlackRock Inc. now owns 1,631,993 shares of the health services provider’s stock valued at $229,377,000 after acquiring an additional 32,146 shares during the last quarter.

About athenahealth

athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.

The Fly

Analyst Recommendations for athenahealth (NASDAQ:ATHN)

Receive News & Ratings for athenahealth Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth Inc. and related companies with MarketBeat.com's FREE daily email newsletter.